AstraZeneca (AZN.US) has launched Fanzhuozhuo in China for the maintenance treatment of severe eosinophilic asthma.

AstraZeneca (AZN.US) has launched Fasenra in China for the maintenance treatment of severe eosinophilic asthma (SEA).

Zhitong FinanceMar 25 02:37 ET

AstraZeneca Seeks to Move Past China Probe With Beijing R&D Hub

The Edge MarketsMar 25 01:12 ET

Hong Kong stocks move | HBM HOLDINGS-B (02142) rose nearly 8% in the morning, reaching a significant strategic cooperation with AstraZeneca. The premium share issuance received over 0.1 billion USD.

HBM HOLDINGS-B (02142) rose nearly 8% in the morning session, and as of the time of writing, it has increased by 4.96%, priced at 8.67 HKD, with a transaction volume of 44.4601 million HKD.

Zhitong FinanceMar 24 22:19 ET

Trump to Nominate Acting CDC Director Monarez to Lead Agency - Report

Seeking AlphaMar 24 15:41 ET

AstraZeneca Hits 4-week Low

Trading EconomicsMar 24 06:05 ET

Assemblin Caverion Group Unit to Upgrade AstraZeneca's Swedish Plant

MT NewswiresMar 24 03:36 ET